Heinävaara Sirpa, Sarkeala Tytti, Anttila Ahti
Finnish Cancer Registry/Mass Screening Registry, Unioninkatu 22, 00130 Helsinki, Finland.
Br J Cancer. 2016 Apr 26;114(9):1038-44. doi: 10.1038/bjc.2016.68. Epub 2016 Mar 24.
The usefulness of case-control studies has been questioned. Our aim was to evaluate the long-term effect of screening on breast cancer mortality within the population-based mammography programme in Finland using a case-control design, and to compare the analyses with the earlier cohort study.
The cases were women invited to screening, diagnosed and died from breast cancer in 1992-2011 while being 50-84 years at death. We chose 10 controls for each case with non-restrictive eligibility criteria. Our data included 1907 cases and 18 978 matched controls. We analysed associations between the screening participation and the risk of breast cancer death using the conditional Cox proportional hazards model. The effect estimates were corrected for self-selection bias.
An overall effect of screening was 0.67 (95% confidence interval (CI): 0.49-0.90), and that remained unchanged over time. Analyses with matching criteria comparable to the cohort study yielded an effect (0.70, 95% CI: 0.49-1.00) in 1992-2003 similar to that of the previous cohort analysis (0.72, 95% CI: 0.56-0.88).
Organised mammography screening decreases mortality from breast cancer by 33% among the participants. If made comparable, a case-cohort study can yield effect estimates similar to a cohort study.
病例对照研究的实用性受到了质疑。我们的目的是采用病例对照设计,评估芬兰基于人群的乳房X线筛查计划中筛查对乳腺癌死亡率的长期影响,并将分析结果与早期的队列研究进行比较。
病例为1992年至2011年间受邀参加筛查、被诊断为乳腺癌并死于该病的女性,死亡时年龄在50至84岁之间。我们为每个病例选择10名对照,对照的纳入标准无限制。我们的数据包括1907例病例和18978名匹配的对照。我们使用条件Cox比例风险模型分析筛查参与情况与乳腺癌死亡风险之间的关联。对效应估计值进行了自我选择偏倚校正。
筛查的总体效应为0.67(95%置信区间(CI):0.49 - 0.90),且随时间保持不变。采用与队列研究相当的匹配标准进行分析,在1992年至2003年得出的效应为0.70(95%CI:0.49 - 1.00),与先前队列分析的结果(0.72,95%CI:0.56 - 0.88)相似。
有组织的乳房X线筛查可使参与者的乳腺癌死亡率降低33%。如果条件可比,病例队列研究可得出与队列研究相似的效应估计值。